Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2 - PubMed (original) (raw)
Clinical Trial
. 2002 Feb 10;97(5):557-61.
doi: 10.1002/ijc.10109.
Affiliations
- PMID: 11807777
- DOI: 10.1002/ijc.10109
Clinical Trial
Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2
Thomas A Buchholz et al. Int J Cancer. 2002.
Abstract
The BRCA1 and BRCA2 gene products are thought to play important roles in the processing of DNA damage. To assess whether heterozygous mutations in these genes are associated with cellular radiosensitivity, we performed an in vitro radiation clonogenic survival assay on dermal fibroblasts obtained from 8 sequence-proven BRCA heterozygotes (6 BRCA1, 2 BRCA2). These data were compared to results obtained from a previous set of 17 prospectively studied cancer patients who had a negligible risk for a BRCA mutation. In addition, results from radiation-induced chromatid break assay performed on lymphocytes obtained from 9 BRCA heterozygotes (8 BRCA1, 1 BRCA2) were compared to results from a control group of 18 women with no cancer history. Results from both assays suggested that cells containing a heterozygous mutation in BRCA1 or BRCA2 were more radiosensitive than controls. For the fibroblast studies, the mean surviving fraction at 2 Gy (SF2) for carriers was 0.279 vs. 0.348 for the control set (p = 0.007). For the lymphocyte studies, the mean number of chromatid breaks after 125 cGy of radiation was 0.79 breaks per cell for the carriers vs. 0.45 for the controls (p = 0.0005). There was no apparent difference in the radiosensitivity between cells with BRCA1 vs. BRCA2 mutations (p = 0.769), although the small sample size minimizes the certainty of this observation. These preliminary results are consistent with a relationship between a germline mutation in BRCA1 or BRCA2 and a hypersensitivity to radiation. This phenotype could possibly predispose to an increased risk of radiation-induced mutagenesis and carcinogenesis.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
- Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers.
Baeyens A, Thierens H, Claes K, Poppe B, de Ridder L, Vral A. Baeyens A, et al. Int J Radiat Biol. 2004 Oct;80(10):745-56. doi: 10.1080/09553000400017937. Int J Radiat Biol. 2004. PMID: 15799620 - Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility.
Barwell J, Pangon L, Georgiou A, Kesterton I, Langman C, Arden-Jones A, Bancroft E, Salmon A, Locke I, Kote-Jarai Z, Morris JR, Solomon E, Berg J, Docherty Z, Camplejohn R, Eeles R, Hodgson SV. Barwell J, et al. Int J Cancer. 2007 Oct 1;121(7):1631-6. doi: 10.1002/ijc.22915. Int J Cancer. 2007. PMID: 17582599 - Increased chromosomal radiosensitivity in women carrying BRCA1/BRCA2 mutations assessed with the G2 assay.
Ernestos B, Nikolaos P, Koulis G, Eleni R, Konstantinos B, Alexandra G, Michael K. Ernestos B, et al. Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1199-205. doi: 10.1016/j.ijrobp.2009.10.020. Int J Radiat Oncol Biol Phys. 2010. PMID: 20206018 - A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
Vos S, van Diest PJ, Moelans CB. Vos S, et al. Crit Rev Oncol Hematol. 2018 Jul;127:29-41. doi: 10.1016/j.critrevonc.2018.05.008. Epub 2018 May 14. Crit Rev Oncol Hematol. 2018. PMID: 29891109 Review. - Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
Speit G, Trenz K. Speit G, et al. Cytogenet Genome Res. 2004;104(1-4):325-32. doi: 10.1159/000077511. Cytogenet Genome Res. 2004. PMID: 15162060 Review.
Cited by
- Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.
Bermes M, Rodriguez MJ, de Toledo MAS, Ernst S, Müller-Newen G, Brümmendorf TH, Chatain N, Koschmieder S, Baumeister J. Bermes M, et al. Int J Mol Sci. 2023 Dec 16;24(24):17560. doi: 10.3390/ijms242417560. Int J Mol Sci. 2023. PMID: 38139386 Free PMC article. - Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation.
Baert A, Depuydt J, Van Maerken T, Poppe B, Malfait F, Storm K, van den Ende J, Van Damme T, De Nobele S, Perletti G, De Leeneer K, Claes KB, Vral A. Baert A, et al. Breast Cancer Res. 2016 May 17;18(1):52. doi: 10.1186/s13058-016-0709-1. Breast Cancer Res. 2016. PMID: 27184744 Free PMC article. - Influence of homologous recombinational repair on cell survival and chromosomal aberration induction during the cell cycle in gamma-irradiated CHO cells.
Wilson PF, Hinz JM, Urbin SS, Nham PB, Thompson LH. Wilson PF, et al. DNA Repair (Amst). 2010 Jul 1;9(7):737-44. doi: 10.1016/j.dnarep.2010.03.009. DNA Repair (Amst). 2010. PMID: 20434408 Free PMC article. - Haploinsufficiency for BRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes.
Latimer JJ, Rubinstein WS, Johnson JM, Kanbour-Shakir A, Vogel VG, Grant SG. Latimer JJ, et al. BMC Med Genet. 2005 Jun 14;6:26. doi: 10.1186/1471-2350-6-26. BMC Med Genet. 2005. PMID: 15955237 Free PMC article. - Functional assays for analysis of variants of uncertain significance in BRCA2.
Guidugli L, Carreira A, Caputo SM, Ehlen A, Galli A, Monteiro AN, Neuhausen SL, Hansen TV, Couch FJ, Vreeswijk MP; ENIGMA consortium. Guidugli L, et al. Hum Mutat. 2014 Feb;35(2):151-64. doi: 10.1002/humu.22478. Epub 2013 Dec 3. Hum Mutat. 2014. PMID: 24323938 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous